-
XLV
-
$157.65
-
-0.49%
-
$158.42
-
$158.25
-
$157.16
Prices as of 2025-11-28 16:20:47 ET
Ticker Appearances
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
What to watch for now to think a reversal might be coming
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
What to watch for now to think a reversal might be coming
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
What to watch for now to think a reversal might be coming
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 20 free reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 20 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In c832eb-c23d8e-98b18a-f46596-130190
Already have an account? Sign In c832eb-c23d8e-98b18a-f46596-130190